Liquid Chromatograph (LC) coupled with Inductively Coupled Plasma Mass Spectrometer (ICP-MS)
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
CDC OFFICE OF ACQUISITION SERVICES
Contract Value
Not provided
Codes & Classification
Solicitation Number
98130
NAICS
334516 - Analytical Laboratory Instrument Manufacturing
Classification Code
6640
Additional Details
The Centers for Disease Control and Prevention (CDC), operating under the Department of Health and Human Services, has issued a Special Notice regarding its intent to award a sole source, firm fixed price purchase order to Agilent Technologies, Inc. The procurement is for a Liquid Chromatograph (LC) coupled with an Inductively Coupled Plasma Mass Spectrometer (ICP-MS), specifically the Agilent 1260 Infinity III LC integrated with the Agilent 7900 ICP-MS. This acquisition is intended for use within the Respiratory Health Division/Field Studies Branch laboratories located in Atlanta, Georgia.
The primary purpose of this procurement is to secure a fully integrated LC-ICP-MS system that is compatible with the laboratory’s existing instrumentation and software platform, namely Agilent MassHunter. The scope of the requirement emphasizes seamless integration with established analytical workflows, including instrument control, data acquisition, and data analysis. The intended outcome is to maintain continuity of validated analytical methods, minimize training requirements and operational downtime, and ensure consistent data processing and reporting across platforms. The CDC has determined that only the Agilent system can meet these requirements, as no other vendor offers an LC-ICP-MS solution that integrates with the MassHunter software environment currently in use.
Key requirements and objectives include:
- Direct integration with existing MassHunter software for instrument control and data analysis.
- Continuity of validated analytical methods and workflows, avoiding the need for modification or redevelopment.
- Minimization of retraining and operational downtime for laboratory personnel.
- Consistent data processing and reporting across all platforms.
- Efficient implementation within the existing laboratory infrastructure.
Market research conducted by the CDC identified only one other vendor capable of providing an LC-ICP-MS system with similar analytical capabilities. However, this alternative does not meet the government’s requirements for software compatibility, would necessitate retraining personnel, require modification and revalidation of analytical methods, and introduce delays and risks to ongoing research activities. Additionally, the alternative system was approximately $100,000 more expensive and did not offer equivalent operational efficiency. Based on these findings, Agilent Technologies, Inc. is considered the only reasonable source for this procurement.
The procurement is classified under NAICS Code 334516 (Analytical Laboratory Instrument Manufacturing, 2022 version) and Product Service Code 6640. The place of performance is Atlanta, Georgia, United States. The contracting entity is the CDC Office of Acquisition Services, a federal office within the Centers for Disease Control and Prevention.
This contract action is being conducted under the authority of FAR 6.103-1 (Simplified Acquisition Procedures), and is not a request for competitive quotations. However, the CDC will consider any quotations or responses received within 15 days of the notice issuance for the purpose of determining whether to conduct a competitive procurement. Interested parties should submit their responses via email to Iris Gonzalez, Contract Specialist, at [email protected] by June 13, 2026, before 10am EST.
Contractors evaluating this opportunity should note that the requirement for seamless integration with the existing Agilent MassHunter software and laboratory workflows is a constant and critical element throughout the contract lifecycle. The CDC’s focus on operational continuity, efficiency, and data consistency underscores the importance of compatibility and validated methods in its research environment.
For further information, the notice is available on SAM.gov under Opportunity ID 1073c2469a81438bb99f160525653fe2. The notice remains active, and no attachments or additional documents are provided at this time.